Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Frick

Showing results (81-90 of 86) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 86 results.
Folia Haematologica (Leipzig, Germany : 1928)|January 1, 1976
[Behavior of the heparinocytes after gold therapy]G Frick, U Frick, C Engelmann, et al.
Aktuelle Radiologie|November 1, 1994
[The value of various ultrasound criteria in objective assessment of acute reactive cholecystitis. A prospective follow-up study of ventilated intensive care patients]N Rilinger, M Pascu, H J Häberle, et al.
ACS Nano|October 11, 2016
Interleukin-2 Functionalized Nanocapsules for T Cell-Based ImmunotherapyStefanie U Frick, Matthias P Domogalla, Grit Baier, et al.
European Archives of Psychiatry and Clinical Neuroscience|January 1, 1992
Depressive syndromes in schizophrenic patients under neuroleptic therapy. ANI Study Group Berlin, Düsseldorf, Göttingen, Munich, Federal Republic of GermanyB Bandelow, P Müller, U Frick, et al.
The British Journal of Psychiatry. Supplement|September 1, 1993
Early neuroleptic intervention in schizophrenia: are prodromal symptoms valid predictors of relapse?W Gaebel, U Frick, W Köpcke, et al.
American Journal of Medical Genetics|July 14, 2000
Association of dopamine D3-receptor gene variants with neuroleptic induced akathisia in schizophrenic patients: a generalization of Steen's study on DRD3 and tardive dyskinesiaP Eichhammer, M Albus, M Borrmann-Hassenbach, et al.
Pageof 9

Showing results (81-90 of 86) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 86 results.
Folia Haematologica (Leipzig, Germany : 1928)|January 1, 1976
[Behavior of the heparinocytes after gold therapy]G Frick, U Frick, C Engelmann, et al.
Aktuelle Radiologie|November 1, 1994
[The value of various ultrasound criteria in objective assessment of acute reactive cholecystitis. A prospective follow-up study of ventilated intensive care patients]N Rilinger, M Pascu, H J Häberle, et al.
ACS Nano|October 11, 2016
Interleukin-2 Functionalized Nanocapsules for T Cell-Based ImmunotherapyStefanie U Frick, Matthias P Domogalla, Grit Baier, et al.
European Archives of Psychiatry and Clinical Neuroscience|January 1, 1992
Depressive syndromes in schizophrenic patients under neuroleptic therapy. ANI Study Group Berlin, Düsseldorf, Göttingen, Munich, Federal Republic of GermanyB Bandelow, P Müller, U Frick, et al.
The British Journal of Psychiatry. Supplement|September 1, 1993
Early neuroleptic intervention in schizophrenia: are prodromal symptoms valid predictors of relapse?W Gaebel, U Frick, W Köpcke, et al.
American Journal of Medical Genetics|July 14, 2000
Association of dopamine D3-receptor gene variants with neuroleptic induced akathisia in schizophrenic patients: a generalization of Steen's study on DRD3 and tardive dyskinesiaP Eichhammer, M Albus, M Borrmann-Hassenbach, et al.
Pageof 9